Ray K, Bhattacharyya B, Biswas B B
J Biol Chem. 1981 Jun 25;256(12):6241-4.
The chemical specificity of the colchicine-binding site of tubulin is less stringent for the presence of the B-ring than the A- and C-rings of colchicine, Colchicine analogues with modifications in the B-ring bind to tubulin at the same site as colchicine. Analogues with smaller or no substituents in the B-ring bind tubulin remarkably faster than colchicine. Thus, a compound without the B-ring [2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone] binds tubulin even at 4 degrees C and the binding is almost instantaneous at 37 degrees C. Colcemid and 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone bind reversibly to tubulin, whereas colchicine and desacetamidocolchicine bind almost irreversibly, suggesting that the size of the B-ring moiety of colchicine is not related to the reversibility of binding. We conclude that although the presence of the B-ring of colchicine does not appear to be an essential prerequisite for the drug-tubulin interaction, the B-ring substituents play an important role in determining the binding properties of colchicine to tubulin.
与秋水仙碱的A环和C环相比,微管蛋白上秋水仙碱结合位点对B环存在的化学特异性要求没那么严格。B环有修饰的秋水仙碱类似物与秋水仙碱在微管蛋白的同一位点结合。B环上取代基较小或没有取代基的类似物与微管蛋白结合的速度比秋水仙碱快得多。因此,一种没有B环的化合物[2-甲氧基-5-(2',3',4'-三甲氧基苯基)色酮]即使在4℃时也能与微管蛋白结合,在37℃时结合几乎是瞬间完成的。秋水仙酰胺和2-甲氧基-5-(2',3',4'-三甲氧基苯基)色酮与微管蛋白可逆结合,而秋水仙碱和去乙酰氨基秋水仙碱几乎不可逆结合,这表明秋水仙碱B环部分的大小与结合的可逆性无关。我们得出结论,虽然秋水仙碱B环的存在似乎不是药物与微管蛋白相互作用的必要前提,但B环取代基在决定秋水仙碱与微管蛋白的结合特性方面起着重要作用。